PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Schiff, Michael
TI  - One-Year Results from the AMPLE Study
DP  - 2012 Sep 01
TA  - MD Conference Express
PG  - 7--7
VI  - 12
IP  - 9
4099  - http://mdc.sagepub.com/content/12/9/7.short
4100  - http://mdc.sagepub.com/content/12/9/7.full
AB  - To date, no randomized, controlled studies have directly compared the safety and efficacy of different biologic disease-modifying antirheumatic drugs in rheumatoid arthritis (RA). This article presents the 1-year results of the Abatacept Versus Adalimumab Comparison in Biologic-Naïve RA Subjects With Background Methotrexate study [AMPLE; NCT00929864], that compared the efficacy and safety of subcutaneous abatacept versus adalimumab, both with background methotrexate.